INSP Financial Statements

Balance sheet, income statement, cash flow, and dividends for Inspire Medical Systems Inc (INSP).


$5.56B Market Cap.

As of 02/10/2025 5:00 PM ET (MRY) • Disclaimer

INSP Market Cap. (MRY)


INSP Shares Outstanding (MRY)


INSP Assets (MRY)


Total Assets

$808.38M

Total Liabilities

$118.69M

Total Investments

$366.39M

INSP Income (MRY)


Revenue

$802.80M

Net Income

$53.51M

Operating Expense

$643.74M

INSP Cash Flow (MRY)


CF Operations

$130.25M

CF Investing

-$113.12M

CF Financing

-$52.39M

INSP Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

INSP Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$808,383,000 (19.44%)

$676,811,000 (19.82%)

$564,876,000 (91.43%)

$295,084,000 (4.94%)

Assets Current

$630,806,000 (6.24%)

$593,739,000 (12.02%)

$530,032,000 (97.38%)

$268,537,000 (-0.49%)

Assets Non-Current

$177,577,000 (113.76%)

$83,072,000 (138.41%)

$34,844,000 (31.25%)

$26,547,000 (134.51%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$689,695,000 (20.47%)

$572,514,000 (15.42%)

$496,008,000 (116.55%)

$229,048,000 (-0.30%)

Property Plant & Equipment Net

$95,239,000 (52.02%)

$62,651,000 (159.65%)

$24,129,000 (47.08%)

$16,405,000 (47.58%)

Cash & Equivalents

$150,150,000 (-19.07%)

$185,537,000 (-57.98%)

$441,592,000 (105.90%)

$214,467,000 (12.57%)

Accumulated Other Comprehensive Income

$536,000 (-33.00%)

$800,000 (1030.23%)

-$86,000 (-56.36%)

-$55,000 (-289.66%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$366,391,000 (29.02%)

$283,981,000 (2791.57%)

$9,821,000 (-1.18%)

$9,938,000 (-77.33%)

Investments Current

$295,396,000 (7.48%)

$274,838,000 (2698.47%)

$9,821,000 (0%)

$0 (0%)

Investments Non-Current

$70,995,000 (676.50%)

$9,143,000 (0%)

$0 (0%)

$9,938,000 (0%)

Inventory

$80,118,000 (136.44%)

$33,885,000 (185.08%)

$11,886,000 (-31.02%)

$17,231,000 (103.22%)

Trade & Non-Trade Receivables

$93,068,000 (3.54%)

$89,884,000 (46.80%)

$61,228,000 (79.14%)

$34,179,000 (36.37%)

Trade & Non-Trade Payables

$38,687,000 (-0.39%)

$38,839,000 (44.67%)

$26,847,000 (130.15%)

$11,665,000 (61.81%)

Accumulated Retained Earnings (Deficit)

-$291,914,000 (15.49%)

-$345,423,000 (-6.52%)

-$324,270,000 (-16.06%)

-$279,389,000 (-17.71%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$30,039,000 (20.90%)

$24,846,000 (229.70%)

$7,536,000 (-77.69%)

$33,783,000 (10.29%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$9,188,000 (0%)

Debt Non-Current

$30,039,000 (20.90%)

$24,846,000 (229.70%)

$7,536,000 (-69.36%)

$24,595,000 (-19.71%)

Total Liabilities

$118,688,000 (13.80%)

$104,297,000 (51.44%)

$68,868,000 (4.29%)

$66,036,000 (28.37%)

Liabilities Current

$88,501,000 (13.31%)

$78,105,000 (27.65%)

$61,186,000 (48.13%)

$41,307,000 (99.31%)

Liabilities Non-Current

$30,187,000 (15.25%)

$26,192,000 (240.95%)

$7,682,000 (-68.94%)

$24,729,000 (-19.49%)

INSP Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$802,804,000 (28.49%)

$624,799,000 (53.19%)

$407,856,000 (74.75%)

$233,394,000 (102.28%)

Cost of Revenue

$122,986,000 (27.35%)

$96,576,000 (46.07%)

$66,115,000 (98.67%)

$33,279,000 (88.84%)

Selling General & Administrative Expense

$529,607,000 (17.18%)

$451,958,000 (40.93%)

$320,688,000 (58.27%)

$202,615,000 (58.45%)

Research & Development Expense

$114,128,000 (-2.07%)

$116,536,000 (69.77%)

$68,645,000 (83.79%)

$37,350,000 (43.15%)

Operating Expenses

$643,735,000 (13.24%)

$568,494,000 (46.02%)

$389,333,000 (62.25%)

$239,965,000 (55.86%)

Interest Expense

$22,000 (0%)

$0 (0%)

$1,677,000 (-21.19%)

$2,128,000 (0.52%)

Income Tax Expense

$4,944,000 (296.47%)

$1,247,000 (103.43%)

$613,000 (751.39%)

$72,000 (-37.39%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$53,509,000 (352.96%)

-$21,153,000 (52.87%)

-$44,881,000 (-6.75%)

-$42,042,000 (26.50%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

$53,509,000 (352.96%)

-$21,153,000 (52.87%)

-$44,881,000 (-6.75%)

-$42,042,000 (26.50%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

$53,509,000 (352.96%)

-$21,153,000 (52.87%)

-$44,881,000 (-6.75%)

-$42,042,000 (26.50%)

Weighted Average Shares

$29,763,395 (1.57%)

$29,302,154 (4.38%)

$28,071,748 (2.97%)

$27,262,979 (4.56%)

Weighted Average Shares Diluted

$30,543,274 (4.24%)

$29,302,154 (4.38%)

$28,071,748 (2.97%)

$27,262,979 (4.56%)

Earning Before Interest & Taxes (EBIT)

$58,475,000 (393.76%)

-$19,906,000 (53.26%)

-$42,591,000 (-6.90%)

-$39,842,000 (27.52%)

Gross Profit

$679,818,000 (28.70%)

$528,223,000 (54.57%)

$341,741,000 (70.77%)

$200,115,000 (104.70%)

Operating Income

$36,083,000 (189.60%)

-$40,271,000 (15.38%)

-$47,592,000 (-19.43%)

-$39,850,000 (29.10%)

INSP Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$113,122,000 (61.63%)

-$294,822,000 (-1404.50%)

-$19,596,000 (-167.25%)

$29,139,000 (-66.36%)

Net Cash Flow from Financing

-$52,393,000 (-475.58%)

$13,950,000 (-94.07%)

$235,077,000 (1472.63%)

$14,948,000 (-88.85%)

Net Cash Flow from Operations

$130,246,000 (428.32%)

$24,653,000 (113.10%)

$11,569,000 (157.50%)

-$20,119,000 (62.07%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$35,387,000 (86.18%)

-$256,055,000 (-212.74%)

$227,125,000 (848.37%)

$23,949,000 (-85.72%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$73,999,000 (72.71%)

-$271,193,000 (-2482.79%)

-$10,500,000 (-131.06%)

$33,807,000 (-62.05%)

Capital Expenditure

-$39,123,000 (-65.57%)

-$23,629,000 (-159.77%)

-$9,096,000 (-94.86%)

-$4,668,000 (-90.14%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

-$24,500,000 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

-$47,228,000 (-251.82%)

$31,108,000 (-88.02%)

$259,620,000 (1636.82%)

$14,948,000 (-88.85%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$118,000 (-171.95%)

$164,000 (118.67%)

$75,000 (494.74%)

-$19,000 (-272.73%)

Share Based Compensation

$116,007,000 (40.67%)

$82,470,000 (58.69%)

$51,970,000 (98.53%)

$26,178,000 (104.24%)

Depreciation Amortization & Accretion

$6,550,000 (54.26%)

$4,246,000 (46.51%)

$2,898,000 (45.70%)

$1,989,000 (9.77%)

INSP Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

84.70% (0.24%)

84.50% (0.84%)

83.80% (-2.22%)

85.70% (1.18%)

Profit Margin

6.70% (297.06%)

-3.40% (69.09%)

-11.00% (38.89%)

-18.00% (63.71%)

EBITDA Margin

8.10% (424.00%)

-2.50% (74.23%)

-9.70% (40.12%)

-16.20% (64.86%)

Return on Average Equity (ROAE)

8.20% (310.26%)

-3.90% (69.29%)

-12.70% (32.45%)

-18.80% (32.62%)

Return on Average Assets (ROAA)

7.10% (308.82%)

-3.40% (68.22%)

-10.70% (28.67%)

-15.00% (35.06%)

Return on Sales (ROS)

7.30% (328.13%)

-3.20% (69.23%)

-10.40% (39.18%)

-17.10% (64.08%)

Return on Invested Capital (ROIC)

10.80% (220.00%)

-9.00% (83.96%)

-56.10% (-20.91%)

-46.40% (21.49%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

102.99 (136.45%)

-282.54 (-79.48%)

-157.43 (-5.38%)

-149.39 (-73.94%)

Price to Sales Ratio (P/S)

6.87 (-27.96%)

9.54 (-44.96%)

17.34 (-35.49%)

26.87 (-36.77%)

Price to Book Ratio (P/B)

8.05 (-23.22%)

10.49 (-28.50%)

14.67 (-46.61%)

27.48 (24.62%)

Debt to Equity Ratio (D/E)

0.17 (-5.49%)

0.18 (30.94%)

0.14 (-51.74%)

0.29 (28.57%)

Earnings Per Share (EPS)

1.8 (350.00%)

-0.72 (55.00%)

-1.6 (-3.90%)

-1.54 (29.68%)

Sales Per Share (SPS)

26.97 (26.50%)

21.32 (46.76%)

14.53 (69.71%)

8.56 (93.47%)

Free Cash Flow Per Share (FCFPS)

3.06 (8648.57%)

0.04 (-60.23%)

0.09 (109.68%)

-0.91 (57.30%)

Book Value Per Share (BVPS)

23.17 (18.60%)

19.54 (10.58%)

17.67 (110.32%)

8.4 (-4.66%)

Tangible Assets Book Value Per Share (TABVPS)

27.16 (17.59%)

23.1 (14.78%)

20.12 (85.91%)

10.82 (0.36%)

Enterprise Value Over EBIT (EV/EBIT)

93 (132.52%)

-286 (-77.64%)

-161 (-5.23%)

-153 (-71.91%)

Enterprise Value Over EBITDA (EV/EBITDA)

83.55 (122.95%)

-364.07 (-110.43%)

-173.01 (-7.10%)

-161.54 (-74.82%)

Asset Turnover

1.06 (6.72%)

1 (2.36%)

0.97 (16.79%)

0.83 (78.97%)

Current Ratio

7.13 (-6.24%)

7.6 (-12.25%)

8.66 (33.26%)

6.5 (-50.07%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$91,123,000 (8798.73%)

$1,024,000 (-58.59%)

$2,473,000 (109.98%)

-$24,787,000 (55.34%)

Enterprise Value (EV)

$5,432,972,517 (-4.71%)

$5,701,381,768 (-16.98%)

$6,867,488,689 (12.31%)

$6,114,808,256 (24.48%)

Earnings Before Tax (EBT)

$58,453,000 (393.65%)

-$19,906,000 (55.03%)

-$44,268,000 (-5.48%)

-$41,970,000 (26.48%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$65,025,000 (515.23%)

-$15,660,000 (60.55%)

-$39,693,000 (-4.86%)

-$37,853,000 (28.79%)

Invested Capital

$599,771,000 (36.93%)

$438,015,000 (529.02%)

$69,634,000 (-4.73%)

$73,093,000 (-27.33%)

Working Capital

$542,305,000 (5.17%)

$515,634,000 (9.98%)

$468,846,000 (106.33%)

$227,230,000 (-8.80%)

Tangible Asset Value

$808,383,000 (19.44%)

$676,811,000 (19.82%)

$564,876,000 (91.43%)

$295,084,000 (4.94%)

Market Capitalization

$5,555,266,517 (-7.51%)

$6,006,105,768 (-17.47%)

$7,277,414,689 (15.62%)

$6,294,004,256 (24.23%)

Average Equity

$653,338,000 (21.51%)

$537,675,250 (51.64%)

$354,562,750 (58.93%)

$223,098,250 (8.89%)

Average Assets

$754,702,000 (20.44%)

$626,599,500 (49.71%)

$418,530,250 (49.53%)

$279,899,750 (13.09%)

Invested Capital Average

$540,342,500 (143.84%)

$221,596,000 (191.91%)

$75,912,500 (-11.68%)

$85,954,750 (-7.65%)

Shares

29,966,914 (1.50%)

29,524,189 (2.19%)

28,892,388 (5.61%)

27,358,099 (1.57%)